Your Annual Legislative and Regulatory Update

Description

Pharmacy today is fraught with new legislation and regulation. Constant developments in Congress and federal agencies have implications for pharmacists’ practices. This session will provide the most recent information on congressional activities addressing prescription drug abuse and misuse as well as other legislative efforts impacting the profession, such as provider status. On the regulatory front, speakers will describe federal agency efforts to implement the Drug Quality and Security Act (DQSA), improve Medicare and determine biosimilar naming and labeling requirements.

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Identify new federal legislative activity that will affect the practice of pharmacy.
  2. Describe new federal regulations and activities that will affect the practice of pharmacy.
  3. Discuss the current status of federal reimbursement for pharmacists’ services.

Technician Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Identify new federal legislation that will affect the practice of pharmacy.
  2. Describe new federal regulations and activities that will affect the practice of pharmacy.
  3. Discuss the current status of federal reimbursement for pharmacists’ services..
 
 
 
Speakers:
Michael
Michael Baxter,
Director, Regulatory Affairs
American Pharmacists Association
 
Jenna
Jenna Ventresca,
 
Alicia Kerry
Alicia Kerry Mica,
Senior Lobbyist
American Pharmacists Association
 
Learning Level: Level 2
Pathway: Meeting Highlights Video on Demand
Track: Pharmacy Law and Regulations
Session Time Slot(s): 
Date: 
Saturday, March 25
Time: 
3:00 PM - 5:00 PM
Room: 
Moscone - Esplanade 303
ACPE Pharmacist: 0202-0000-17-046-L03-P
CEUs Pharmacist: .2
ACPE Pharmacy Technician: 0202-0000-17-046-L03-T
CEUs Pharmacy Technician: .2
Activity Type:
Knowledge-based